193 related articles for article (PubMed ID: 38502412)
21. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
22. Systemic conditions associated with increased risk to develop oral squamous cell carcinoma: Systematic review and meta-analysis.
Dos Santos ES; Pérez-de-Oliveira ME; Normando AGC; Gueiros LAM; Rogatto SR; Vargas PA; Lopes MA; da Silva Guerra EN; Leme AFP; Santos-Silva AR
Head Neck; 2022 Dec; 44(12):2925-2937. PubMed ID: 36114663
[TBL] [Abstract][Full Text] [Related]
23. Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation.
Alkhatib DZR; Thi Kim Truong T; Fujii S; Hasegawa K; Nagano R; Tajiri Y; Kiyoshima T
Pathol Res Pract; 2023 Jun; 246():154493. PubMed ID: 37141698
[TBL] [Abstract][Full Text] [Related]
24. To evaluate an association between prognostic significance of Moesin with histopathological grading of oral squamous cell carcinoma: A systematic review.
Bommanavar S; Kanetkar SR; Datkhile KD
J Oral Maxillofac Pathol; 2023; 27(1):148-161. PubMed ID: 37234334
[TBL] [Abstract][Full Text] [Related]
25. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
26. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
27. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
28. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.
Petruzzi MN; Cherubini K; Salum FG; de Figueiredo MA
Diagn Pathol; 2017 Apr; 12(1):32. PubMed ID: 28381274
[TBL] [Abstract][Full Text] [Related]
29. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
31. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
32. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract][Full Text] [Related]
33. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
35. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
Xie S; Cai ZG; Shan XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
[TBL] [Abstract][Full Text] [Related]
36. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
Liu Y; Wang T; Li R
BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
[TBL] [Abstract][Full Text] [Related]
37. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma.
Kuk SK; Lee JI; Kim K
Head Neck Pathol; 2023 Jun; 17(2):409-421. PubMed ID: 36586077
[TBL] [Abstract][Full Text] [Related]
40. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]